We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
International Flavors & Fragrances
IFF
$18.8B
| $343K | 0.01% |
2,540
-6,900
| -73% | -$936K |
|
752
Allegion
ALLE
$13.1B
| $342K | 0.01% |
+4,220
| New | +$330K |
|
|
BELFB
753
Bel Fuse Inc Class B
BELFB
$4.07B
| $342K | 0.01% |
13,851
-2,600
| -16% | -$62.5K |
|
|
ESIO
754
DELISTED
Electro Scientific Industries
ESIO
| $342K | 0.01% |
41,513
-30,652
| -42% | -$236K |
|
755
MacroGenics
MGNX
$255M
| $340K | 0.01% |
19,390
-86,060
| -82% | -$1.64M |
|
|
SPNE
756
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $337K | 0.01% |
29,276
+17,507
| +149% | +$164K |
|
|
CKH
757
DELISTED
Seacor Holdings Inc.
CKH
| $333K | 0.01% |
+10,050
| New | +$533K |
|
758
Boston Beer
SAM
$1.82B
| $330K | 0.01% |
2,500
-4,440
| -64% | -$621K |
|
|
FFKT
759
DELISTED
Farmers Capital Bank Corp
FFKT
| $325K | 0.01% |
8,430
+3,000
| +55% | +$119K |
|
760
Alkermes
ALKS
$8.83B
| $324K | 0.01% |
+5,590
| New | +$325K |
|
|
LEAF
761
DELISTED
Leaf Group Ltd.
LEAF
| $324K | 0.01% |
41,515
+15,379
| +59% | +$125K |
|
762
Community Health Systems
CYH
$392M
| $321K | 0.01% |
+32,200
| New | +$294K |
|
763
Digital Realty Trust
DLR
$66.4B
| $321K | 0.01% |
+2,840
| New | +$325K |
|
764
Antero Resources
AR
$10.9B
| $318K | 0.01% |
14,700
-396,855
| -96% | -$8.52M |
|
765
Grand Canyon Education
LOPE
$3.69B
| $318K | 0.01% |
+4,060
| New | +$311K |
|
766
Insmed
INSM
$23.3B
| $311K | 0.01% |
+18,150
| New | +$310K |
|
767
Monster Beverage
MNST
$91.5B
| $306K | 0.01% |
+12,300
| New | +$296K |
|
|
VAR
768
DELISTED
Varian Medical Systems, Inc.
VAR
| $302K | 0.01% |
2,930
+730
| +33% | +$70.3K |
|
|
PMC
769
DELISTED
PharMerica Corporation
PMC
| $300K | 0.01% |
11,428
-19,372
| -63% | -$476K |
|
770
ePlus
PLUS
$2.27B
| $299K | 0.01% |
8,080
-8,440
| -51% | -$306K |
|
771
Stewart Information Services
STC
$1.95B
| $297K | 0.01% |
6,550
+1,130
| +21% | +$50.9K |
|
772
Clorox
CLX
$11.3B
| $296K | 0.01% |
2,220
+40
| +2% | +$5.4K |
|
773
Masco
MAS
$15.6B
| $295K | 0.01% |
7,710
-14,180
| -65% | -$519K |
|
774
Curis
CRIS
$9.1M
| $294K | 0.01% |
78
+38
| +95% | +$159K |
|
775
Packaging Corp of America
PKG
$20.8B
| $294K | 0.01% |
+2,640
| New | +$266K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.